U.S. health benefits company Elevance Health, Inc. ELV appears undervalued. It is currently trading at 12.25X forward 12-month earnings, below its five-year median of 13.44X and the industry average ...

The stock's fall snapped a four-day winning streak.

According to Benzinga Pro, Elevance Health's peer group average for short interest as a percentage of float is 5.09%, which ...

Elevance Health settled a class-action lawsuit over denial of coverage for minimally invasive sacroiliac joint fusion surgery ...

Shares of Elevance Health, Inc. (NYSE:ELV – Get Free Report) have been assigned an average rating of “Moderate Buy” from the ...

Argus upgraded Elevance Health (ELV) to Buy from Hold with a $450 price target Light Up your Portfolio with Spark:Easily identify stocks' risks ...

Elevance Health (NYSE:ELV – Get Free Report) was downgraded by investment analysts at StockNews.com from a “buy” rating to a “hold” rating in a research note issued to investors on Wednesday. A number ...

Regulatory changes under Trump's administration and AI integration are key factors influencing Elevance Health's future ...

Elevance Health Inc. closed 26.44% below its 52-week high of $567.26, which the company reached on September 3rd.

Elevance Health Inc. signed a class settlement valued at more than $2.5 million in a lawsuit saying it wrongly denied ...